K

Kanvas Biosciences

HealthUnited States

Kanvas Biosciences is focused on developing microbiome-based cancer therapies, leveraging a breakthrough imaging platform to map the gut microbiome. The company aims to improve cancer immunotherapy outcomes and address malnutrition-related gut diseases, with its foundational technology emerging from research at Cornell University.

$48M · Series AVisit website ↗

Funding history

  1. $48MSeries A2026-06-08
    Source: news.google.com ↗

Founder

H
Hao Shi
Co-founder

Investors in Kanvas Biosciences

Backers from this company's tracked funding rounds.

  • DCVC
  • Lions Capital

More Health companies

Recently funded startups in the same category.

Related on Datapile